Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study
DOI:
https://doi.org/10.2340/actadv.v104.40971Keywords:
Alopecia areata, Complete blood count, Platelet to lymphocyte ratio, Systemic immune inflammatory indexAbstract
Previous studies have suggested that alopecia areata (AA) is an organ-specific disease characterized by loss of immune privilege of hair follicles. However, an increasing body of research indicates that it not only affects the skin but may also be accompanied by systemic inflammatory reactions. Therefore, searching for simple and easily available biomarkers to describe the underlying systemic inflammation in AA patients is of great clinical significance. Complete blood collection-based systemic inflammation biomarkers have been shown to be associated with the severity and prognosis of various skin and autoimmune diseases. They involve multiple cell lineages and can reveal different pathways of immune-inflammatory responses. The aim of this study was to investigate the level of complete blood collection-based systemic inflammation biomarkers in patients with AA, and to analyse their relationship with the disease severity. A total of 302 AA patients and 296 healthy controls were included in this study and the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), systemic immune inflammation index (SII), and white blood cell/lymphocyte ratio (WLR) were calculated. The differences in these indicators between the 2 groups were compared, and the relationship between NLR, PLR, SII, WLR, and the risk of severe AA were analysed. AA patients had higher NLR, SII, and WLR compared with healthy controls (p = 0.004, 0.002, and 0.002 respectively). PLR and SII were higher in the severe AA group compared with the mild-to-moderate AA patients (p = 0.005 and 0.011 respectively). The risk of severe AA increased with the increasing of PLR, SII, NLR, and WLR (p for trend was 0.001, 0.006, 0.022, and 0.021, respectively). The levels of systemic inflammation biomark-ers in AA patients are higher than in healthy people. NLR, PLR, SII, and WLR are risk factors for severe AA, suggesting a close association between systemic inflammation and disease occurrence in AA patients.
Downloads
References
Dhillon S. Tofacitinib: a review in rheumatoid arthritis. Drugs 2017; 77: 1987-2001.
https://doi.org/10.1007/s40265-017-0835-9 DOI: https://doi.org/10.1007/s40265-017-0835-9
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-188, quiz 189-190.
https://doi.org/10.1016/j.jaad.2009.10.032 DOI: https://doi.org/10.1016/j.jaad.2009.10.032
Group ACSS, Moussa A, Bennett M, Wall D, Meah N, York K, et al. The Alopecia Areata Severity and Morbidity Index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity. JAMA Dermatol 2024; 160: 341-350.
https://doi.org/10.1001/jamadermatol.2023.5869 DOI: https://doi.org/10.1001/jamadermatol.2023.5869
Glickman JW, Dubin C, Renert-Yuval Y, Dahabreh D, Kimmel GW, Auyeung K, et al. Cross-sectional study of blood biomarkers of patients with moderate to severe
alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation. J Am Acad Dermatol 2021; 84: 370-380.
https://doi.org/10.1016/j.jaad.2020.04.138 DOI: https://doi.org/10.1016/j.jaad.2020.04.138
Waskiel-Burnat A, Osinska M, Salinska A, Blicharz L, Goldust M, Olszewska M, et al. The role of serum th1, th2, and th17 cytokines in patients with alopecia areata: clinical implications. Cells 2021; 10: 3397.
https://doi.org/10.3390/cells10123397 DOI: https://doi.org/10.3390/cells10123397
Bain KA, McDonald E, Moffat F, Tutino M, Castelino M, Barton A, et al. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity. Br J Dermatol 2020; 182: 130-137.
https://doi.org/10.1111/bjd.18008 DOI: https://doi.org/10.1111/bjd.18008
Glickman JW, Dubin C, Dahabreh D, Han J, Del Duca E, Estrada YD, et al. An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata. Allergy 2021; 76: 3053-3065.
https://doi.org/10.1111/all.14814 DOI: https://doi.org/10.1111/all.14814
Ly S, Manjaly P, Kamal K, Shields A, Wafae B, Afzal N, et al. Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis. Am J Clin Dermatol 2023; 24: 875-893.
https://doi.org/10.1007/s40257-023-00805-4 DOI: https://doi.org/10.1007/s40257-023-00805-4
Egeberg A, Anderson S, Edson-Heredia E, Burge R. Comorbidities of alopecia areata: a population-based cohort study. Clin Exp Dermatol 2021; 46: 651-656.
https://doi.org/10.1111/ced.14507 DOI: https://doi.org/10.1111/ced.14507
Hao X, Li D, Wu D, Zhang N. The relationship between hematological indices and autoimmune rheumatic diseases (ARDs), a meta-analysis. Sci Rep 2017; 7: 10833.
https://doi.org/10.1038/s41598-017-11398-4 DOI: https://doi.org/10.1038/s41598-017-11398-4
Langley BO, Guedry SE, Goldenberg JZ, Hanes DA, Beardsley JA, Ryan JJ. Inflammatory bowel disease and neutrophil-lymphocyte ratio: a systematic scoping review. J Clin Med 2021; 10: 4219.
https://doi.org/10.3390/jcm10184219 DOI: https://doi.org/10.3390/jcm10184219
Ma R, Cui L, Cai J, Yang N, Wang Y, Chen Q, et al. Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Front Immunol 2024; 15: 1323174.
https://doi.org/10.3389/fimmu.2024.1323174 DOI: https://doi.org/10.3389/fimmu.2024.1323174
Dere G, Gundogdu M. Investigation of the relationship between alopecia areata and inflammatory blood parameters. J Cosmet Dermatol 2021; 20: 4048-4051.
https://doi.org/10.1111/jocd.14048 DOI: https://doi.org/10.1111/jocd.14048
İslamoğlu ZGK, Demirbas A. Evaluation of complete blood cell and inflammatory parameters in patients with alopecia areata: their association with disease severity. J Cosmet Dermatol 2020; 19: 1239-1245.
https://doi.org/10.1111/jocd.13131 DOI: https://doi.org/10.1111/jocd.13131
Takahashi R, Kinoshita-Ise M, Yamazaki Y, Fukuyama M, Ohyama M. Increase in CD8(+) effector memory T cells re-expressing CD45RA correlates with intractability of severe alopecia areata. J Invest Dermatol 2024; 144: 1654-1657.e7.
https://doi.org/10.1016/j.jid.2024.01.006 DOI: https://doi.org/10.1016/j.jid.2024.01.006
Xu W, Wan S, Xie B, Song X. Novel potential therapeutic targets of alopecia areata. Front Immunol 2023; 14: 1148359.
https://doi.org/10.3389/fimmu.2023.1148359 DOI: https://doi.org/10.3389/fimmu.2023.1148359
Hamed FN, Astrand A, Bertolini M, Rossi A, Maleki-Dizaji A, Messenger AG, et al. Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRbeta-chain, which highlights the immunopathological aspect of the disease. PLoS One 2019; 14: e0210308.
https://doi.org/10.1371/journal.pone.0210308 DOI: https://doi.org/10.1371/journal.pone.0210308
Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013; 13: 159-175.
https://doi.org/10.1038/nri3399 DOI: https://doi.org/10.1038/nri3399
Deniset JF, Kubes P. Recent advances in understanding neutrophils. F1000Res 2016; 5: 2912.
https://doi.org/10.12688/f1000research.9691.1 DOI: https://doi.org/10.12688/f1000research.9691.1
Tarkowski B, Lawniczak J, Tomaszewska K, Kurowski M, Zalewska-Janowska A. Chronic urticaria treatment with omalizumab-verification of NLR, PLR, SIRI and SII as biomarkers and predictors of treatment efficacy. J Clin Med 2023; 12: 2639.
https://doi.org/10.3390/jcm12072639 DOI: https://doi.org/10.3390/jcm12072639
Zhao X, Li J, Li X. Association between systemic immune-inflammation index and psoriasis: a population-based study. Front Immunol 2024; 15: 1305701.
https://doi.org/10.3389/fimmu.2024.1305701 DOI: https://doi.org/10.3389/fimmu.2024.1305701
Utlu Z. Evaluation of systemic immune and inflammatory biomarkers in hidradenitis suppurativa. Eur Rev Med Pharmacol Sci 2023; 27: 9267-9272.
Andersen CSB, Kvist-Hansen A, Siewertsen M, Enevold C, Hansen PR, Kaur-Knudsen D, et al. Blood cell biomarkers of inflammation and cytokine levels as predictors of response to biologics in patients with psoriasis. Int J Mol Sci 2023; 24: 6111.
https://doi.org/10.3390/ijms24076111 DOI: https://doi.org/10.3390/ijms24076111
Published
How to Cite
License
Copyright (c) 2024 Sihan Deng, Jundong Huang, Min Li, Jia Jian, Wei Shi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
